Cargando…

Role of Photobiomodulation Therapy in Neurological Primary Burning Mouth Syndrome. A Systematic Review and Meta-Analysis of Human Randomised Controlled Clinical Trials

Mitochondrial homeostasis is crucial for energy production and neuronal survival in neurological primary burning mouth syndrome (npBMS). Photobiomodulation therapy (PBMT) has been utilised in npBMS management, however, its role of intervention remains controversial. The aim of this systematic review...

Descripción completa

Detalles Bibliográficos
Autores principales: Hanna, Reem, Dalvi, Snehal, Bensadoun, Rene Jean, Raber-Durlacher, Judith E., Benedicenti, Stefano
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8624276/
https://www.ncbi.nlm.nih.gov/pubmed/34834253
http://dx.doi.org/10.3390/pharmaceutics13111838
_version_ 1784606134157443072
author Hanna, Reem
Dalvi, Snehal
Bensadoun, Rene Jean
Raber-Durlacher, Judith E.
Benedicenti, Stefano
author_facet Hanna, Reem
Dalvi, Snehal
Bensadoun, Rene Jean
Raber-Durlacher, Judith E.
Benedicenti, Stefano
author_sort Hanna, Reem
collection PubMed
description Mitochondrial homeostasis is crucial for energy production and neuronal survival in neurological primary burning mouth syndrome (npBMS). Photobiomodulation therapy (PBMT) has been utilised in npBMS management, however, its role of intervention remains controversial. The aim of this systematic review and meta-analysis of CRD 42020198921 PROSPERO registration reference was to oversee and determine the efficacy of PBMT in patients with npBMS, identifying the gaps and bridge them by proposing recommendations for future studies purposes. PRISMA guidelines and Cochrane Collaboration recommendations followed. Various search engines employed to analyse a total of 351 studies of which 12 were included. A wide range of utilised PBM wavelengths was between 635–980 nm and the power output ranged between 30 mW and 4000 mW. A high risk of bias (RoB) was noted in 7 out of 12 included studies (58.3%), as results of qualitative analysis. Meta-analysis findings of 4 out of 12 studies showed statistically significant intergroup differences (SSID) for visual analogue scale (VAS) values (MD = −1.47; 95% CI = −2.40 to −0.53; Z = 3.07 (p = 0.002) whereas meta-analysis on 5 out of 12 studies revealed SSID for anxiety/depression and quality of life (MD = −1.47; 95% CI = −2.40 to −0.53; Z = 3.07 (p = 0.002), favouring PBMT group to the control treatment strategies. Despite the inconsistency and diversity in PBM parameters (wavelength, power, light source, spot size, emission mode, energy per point, total energy) and treatment protocols (exposure time, number of sessions, time interval between sessions, treatment duration)—majority of the included studies showed positive PBM results. The high RoB and meta-analytical heterogeneity in the eligible studies warrant the necessity to perform well-designed and robust RCTs after acknowledging the drawbacks of the available scientific literature and addressing our suggested recommendations highlighted in our review.
format Online
Article
Text
id pubmed-8624276
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-86242762021-11-27 Role of Photobiomodulation Therapy in Neurological Primary Burning Mouth Syndrome. A Systematic Review and Meta-Analysis of Human Randomised Controlled Clinical Trials Hanna, Reem Dalvi, Snehal Bensadoun, Rene Jean Raber-Durlacher, Judith E. Benedicenti, Stefano Pharmaceutics Systematic Review Mitochondrial homeostasis is crucial for energy production and neuronal survival in neurological primary burning mouth syndrome (npBMS). Photobiomodulation therapy (PBMT) has been utilised in npBMS management, however, its role of intervention remains controversial. The aim of this systematic review and meta-analysis of CRD 42020198921 PROSPERO registration reference was to oversee and determine the efficacy of PBMT in patients with npBMS, identifying the gaps and bridge them by proposing recommendations for future studies purposes. PRISMA guidelines and Cochrane Collaboration recommendations followed. Various search engines employed to analyse a total of 351 studies of which 12 were included. A wide range of utilised PBM wavelengths was between 635–980 nm and the power output ranged between 30 mW and 4000 mW. A high risk of bias (RoB) was noted in 7 out of 12 included studies (58.3%), as results of qualitative analysis. Meta-analysis findings of 4 out of 12 studies showed statistically significant intergroup differences (SSID) for visual analogue scale (VAS) values (MD = −1.47; 95% CI = −2.40 to −0.53; Z = 3.07 (p = 0.002) whereas meta-analysis on 5 out of 12 studies revealed SSID for anxiety/depression and quality of life (MD = −1.47; 95% CI = −2.40 to −0.53; Z = 3.07 (p = 0.002), favouring PBMT group to the control treatment strategies. Despite the inconsistency and diversity in PBM parameters (wavelength, power, light source, spot size, emission mode, energy per point, total energy) and treatment protocols (exposure time, number of sessions, time interval between sessions, treatment duration)—majority of the included studies showed positive PBM results. The high RoB and meta-analytical heterogeneity in the eligible studies warrant the necessity to perform well-designed and robust RCTs after acknowledging the drawbacks of the available scientific literature and addressing our suggested recommendations highlighted in our review. MDPI 2021-11-02 /pmc/articles/PMC8624276/ /pubmed/34834253 http://dx.doi.org/10.3390/pharmaceutics13111838 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Systematic Review
Hanna, Reem
Dalvi, Snehal
Bensadoun, Rene Jean
Raber-Durlacher, Judith E.
Benedicenti, Stefano
Role of Photobiomodulation Therapy in Neurological Primary Burning Mouth Syndrome. A Systematic Review and Meta-Analysis of Human Randomised Controlled Clinical Trials
title Role of Photobiomodulation Therapy in Neurological Primary Burning Mouth Syndrome. A Systematic Review and Meta-Analysis of Human Randomised Controlled Clinical Trials
title_full Role of Photobiomodulation Therapy in Neurological Primary Burning Mouth Syndrome. A Systematic Review and Meta-Analysis of Human Randomised Controlled Clinical Trials
title_fullStr Role of Photobiomodulation Therapy in Neurological Primary Burning Mouth Syndrome. A Systematic Review and Meta-Analysis of Human Randomised Controlled Clinical Trials
title_full_unstemmed Role of Photobiomodulation Therapy in Neurological Primary Burning Mouth Syndrome. A Systematic Review and Meta-Analysis of Human Randomised Controlled Clinical Trials
title_short Role of Photobiomodulation Therapy in Neurological Primary Burning Mouth Syndrome. A Systematic Review and Meta-Analysis of Human Randomised Controlled Clinical Trials
title_sort role of photobiomodulation therapy in neurological primary burning mouth syndrome. a systematic review and meta-analysis of human randomised controlled clinical trials
topic Systematic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8624276/
https://www.ncbi.nlm.nih.gov/pubmed/34834253
http://dx.doi.org/10.3390/pharmaceutics13111838
work_keys_str_mv AT hannareem roleofphotobiomodulationtherapyinneurologicalprimaryburningmouthsyndromeasystematicreviewandmetaanalysisofhumanrandomisedcontrolledclinicaltrials
AT dalvisnehal roleofphotobiomodulationtherapyinneurologicalprimaryburningmouthsyndromeasystematicreviewandmetaanalysisofhumanrandomisedcontrolledclinicaltrials
AT bensadounrenejean roleofphotobiomodulationtherapyinneurologicalprimaryburningmouthsyndromeasystematicreviewandmetaanalysisofhumanrandomisedcontrolledclinicaltrials
AT raberdurlacherjudithe roleofphotobiomodulationtherapyinneurologicalprimaryburningmouthsyndromeasystematicreviewandmetaanalysisofhumanrandomisedcontrolledclinicaltrials
AT benedicentistefano roleofphotobiomodulationtherapyinneurologicalprimaryburningmouthsyndromeasystematicreviewandmetaanalysisofhumanrandomisedcontrolledclinicaltrials